IP Verse

Pharmaceutical Composition Comprising Eltrombopag Olamine, Reducing Sugar, And Polymeric Binder - EP3409272

The patent EP3409272 was granted to Alfred E Tiefenbacher on Jun 24, 2020. The application was originally filed on Apr 26, 2018 under application number EP18169614A. The patent is currently recorded with a legal status of "Revoked".

EP3409272

ALFRED E TIEFENBACHER
Application Number
EP18169614A
Filing Date
Apr 26, 2018
Status
Revoked
Nov 18, 2022
Grant Date
Jun 24, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BULLE DRMar 23, 2021KUTZENBERGER WOLFF & PARTNERADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO03098992
DESCRIPTIONWO2008136843
DESCRIPTIONWO2010114943
DESCRIPTIONWO2012121957
DESCRIPTIONWO2015121957
OPPOSITIONEP1207155
OPPOSITIONWO0189457
OPPOSITIONWO03098992
OPPOSITIONWO2004096154
OPPOSITIONWO2008136843
OPPOSITIONWO2012121957
OPPOSITIONWO2015029074
SEARCHEP1207155
SEARCHUS2008090787
SEARCHWO03098992
SEARCHWO2012121957

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- WATERMAN KC, "The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability", AAPS PharmSciTech, (20110900), vol. 12, no. 3
EXAMINATION- NISHANT D. KAMBLI ET AL, "Synthesis and characterization of microcrystalline cellulose powder from corn husk fibres using bio-chemical route", CELLULOSE, Netherlands, (20171012), vol. 24, no. 12, doi:10.1007/s10570-017-1522-4, ISSN 0969-0239, pages 5355 - 5369, XP055543193
OPPOSITION- Anonymous, "Bacterix 200 mg gelule nifuroxazide", Bacterix 200 mg gelule nifuroxazide, (20130618), pages 1 - 2, XP055742326
OPPOSITION- Anonymous, "furadantin tablets 50 mg summary of product characteristics", Mercury Pharmaceutical, (20140901), pages 1 - 8, XP055742337
OPPOSITION- Anonymous, "Handbook of Pharmaceutical excipients", Great Britain, (19860101), XP055967805
OPPOSITION- Anonymous, "Maillard-Reaktion", Römpp Chemie Lexikon, Stuttgart · New York, Stuttgart · New York, (19910101), pages 2605 - 2606, Römpp Chemie Lexikon, (20221004), XP055967743
OPPOSITION- Aulton M.E., "Pharmaceutics - The Science of Dosage Form Design (passage)", Pharmaceutics - The Science of Dosage Form Design, 2nd ed., (20020101), pages 136, 447 - 448, XP055897417
OPPOSITION- G.S. Banker, Et Al, "Racemization", Modern Pharmaceutics, 4th ed. Rev. and Exp., New York , Marcel Dekker , (20020101), pages 222 - 254, XP055314922
OPPOSITION- Herbert A Lieberman, "Unknown", pharmaceutical dosage forms -- tablets 2nd edition, Marcel dekker , (19890101), pages 97 - 98, XP055742353
OPPOSITION- KUMAR V, BANKER G S, "MAILLARD REACTION AND DRUG STABILITY", MAILLARD REACTIONS IN CHEMISTRY, FOOD AND HEALTH., XX, XX, XX , (19940101), pages 20 - 27, XP008015416
OPPOSITION- L. Lachman, Et Al., "The Theory and Practice of Industrial Pharmacy", Lea & Febiger, (19860101), vol. 293, no. 294, pages 324 - 333, XP055762791
OPPOSITION- Remington, "Remington, The Science and Practice of Pharmacy", Remington, Gennaro A.R et al, Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins , (20000101), pages 656,chapter 45, 858 - 870,885,1970, ISBN 978-0-683-30647-7, XP055301025
OPPOSITION- S.S. BHARATE et al., "Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review.", J. Excipients and Food Chem., (20100000), vol. 1, no. 3, pages 3 - 26, XP055131570
OPPOSITION- Swarbrick, Et Al., "ENCYLOPEDIA OF PHARMACEUTICAL TECHNOLOGY", New Yoek, (19910101), XP055967816
OPPOSITION- S. Yoshioka Et Al., "Stability of Drugs and Dosage Forms", (20020101), pages 30 - 33, XP055265867

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents